This federal Project Grant award for $312,883,599.00 from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Opioid State Targeted Response (Opioid STR) program (CFDA 93.788) will support the Florida Department of Children and Families in implementing a comprehensive approach to addressing opioid and stimulant misuse, disorders, and overdoses in Florida. The project aims to reduce opioid-caused deaths by increasing access to medication-assisted treatment and...
The Department of Health and Human Services' Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $183,098,460 Project Grant under the Opioid State Targeted Response (Opioid STR) Program (CFDA 93.788) to the West Virginia Department of Human Services (WVDHS) for the West Virginia State Opioid Response (SOR) Grant. This grant will fund the expansion of evidence-based prevention, early intervention, treatment, and recovery management activities for opioid use disorder (OUD)...
The Ohio Department of Mental Health and Addiction Services (OhioMHAS) received a $400,907,000 Project Grant from the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) under the Opioid STR Federal Grant Program (CFDA 93.788). This grant, awarded on Sep 30, 2024, supports the State Opioid and Stimulant Response (SOS) 4.0 initiative in Ohio. The funding aims to flatten Ohio's opioid and drug poisoning death rate, increase access to harm reduction services, expand...
This $71,160,580 federal Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Opioid State Targeted Response (Opioid STR) program (CFDA 93.788) supports the Wisconsin State Opioid Response (SOR) to address the opioid and stimulant use crisis. The funding will expand access to evidence-based treatment and recovery services, advance prevention and harm reduction efforts, and reduce opioid/stimulant-related overdose deaths, with a focus on...
The Delaware Division of Substance Abuse and Mental Health (DSAMH) received a $155,235,736 Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Opioid State Targeted Response (Opioid STR) program (CFDA 93.788). This 3-year grant aims to enhance and develop Delaware's opioid and stimulant use disorder (OUD/STUD) system of care, with a focus on serving 5 key populations: pregnant/parenting individuals, racial/ethnic minorities,...
The Department of Health and Human Services' Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $60,108,212 Project Grant under the Opioid State Targeted Response (Opioid STR) federal grant program (CFDA 93.788) to the Connecticut Department of Mental Health and Addiction Services (DMHAS) to address the opioid crisis in Connecticut. The grant funding will support a comprehensive, multi-pronged approach, including: 1) continuing efforts to reduce opioid overdose deaths...
The Bureau of Justice Assistance awarded a $7,000,000 Project Grant under the Comprehensive Opioid, Stimulant, and other Substances Use Program (CFDA 16.838) to the Washington State Health Care Authority (HCA). The grant aims to develop and implement a comprehensive initiative to address the needs of individuals who use drugs across the sequential intercept model. Key products and services to be delivered include: Expanding access to evidence-based substance use disorder treatment, such as...
The Health Care Authority (HCA) of Washington State was awarded a $81,377,097 Project Grant from the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program, administered by the Substance Abuse and Mental Health Services Administration (SAMHSA). This grant aims to address Washington's opioid epidemic through five key goals: 1) Prevent opioid and other drug misuse; 2) Identify and treat opioid misuse and stimulant use disorder; 3) Ensure and...
The Tennessee Department of Mental Health and Substance Abuse Services (TDMHSAS) received a $94,080,870 Project Grant award under the Opioid State Targeted Response (Opioid STR) program (CFDA 93.788) from the Substance Abuse and Mental Health Services Administration (SAMHSA). This three-year grant, running from September 30, 2024 to September 29, 2027, aims to enhance the state's prevention, harm reduction, treatment, and recovery activities in response to the opioid epidemic. Key products and...
This Project Grant award for $104,400,264 was made by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Opioid State Targeted Response (Opioid STR) Grant Program (CFDA 93.788). The goal is to reduce the prevalence of opioid and stimulant-related overdose and mortality throughout Arizona. The Arizona Health Care Cost Containment System (AHCCCS), Arizona's state Medicaid agency, will use the funding to increase access to medication-assisted treatment for opioid use...
This federal Project Grant award of $75,500,157, provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Opioid State Targeted Response (Opioid STR) grant program (CFDA 93.788), aims to address the opioid overdose crisis in Washington, D.C. The grant, titled "DCOR 4 - The District of Columbia's Opioid Response 4 (DCOR 4) Initiative," will focus on increasing access to medication for opioid use disorder (MOUD), reducing unmet treatment needs, and decreasing opioid overdose-related deaths through prevention, harm reduction, treatment, and recovery support services. The initiative will serve 2,250 unduplicated individuals over the 3-year grant period.
The grant includes several sub-awards, such as funding prevention centers in D.C. to address opioid use disorder in children and youth, purchasing emergency medical supplies, and providing technical assistance and data support. The sub-awardees include the C.E. Mendez Foundation, Medline Industries, LP, and Health Management Associates Inc.